1.Immune mechanisms of the active ingredients of Chinese medicinal herbs for chronic prostatitis.
Hao WANG ; Yu-chun ZHOU ; Jian-guo XUE
National Journal of Andrology 2016;22(1):63-66
Chronic prostatitis is a common male disease, and its pathogenesis is not yet clear. Most scholars believe that oxidative stress and immune imbalance are the keys to the occurrence and progression of chronic prostatitis. Currently immunotherapy of chronic prostatitis remains in the exploratory stage. This article relates the active ingredients of 5 Chinese medicinal herbs (total glucosides of paeony, tripterigium wilfordii polglycosidium, curcumin, geniposide, and quercetin) for the treatment of chronic prostatitis and their possible action mechanisms as follows: 1) inhibiting the immune response and activation and proliferation of T-cells, and adjusting the proportion of Th1/Th2 cells; 2) upregulating the expression of Treg and enhancing the patient's tolerability; 3) suppressing the activation of the NF-kB factor, reducing the release of iNOS, and further decreasing the release of NO, IL-2 and other inflammatory cytokines, which contribute to the suppression of the immune response; 4) inhibiting the production of such chemokines as MCP-1 and MIP-1α in order to reduce their induction of inflammatory response. Studies on the immune mechanisms of Chinese medicinal herbs in the treatment of chronic prostatitis are clinically valuable for the development of new drugs for this disease.
Chemokines
;
immunology
;
Cytokines
;
immunology
;
Drugs, Chinese Herbal
;
pharmacology
;
Humans
;
Immune System
;
drug effects
;
Male
;
NF-kappa B p50 Subunit
;
metabolism
;
Nitric Oxide Synthase Type II
;
metabolism
;
Plants, Medicinal
;
Prostatitis
;
drug therapy
;
immunology
;
T-Lymphocytes, Regulatory
;
drug effects
;
Th1-Th2 Balance
2.Immunohistochemical Analysis of Nuclear Factor, p38, and Cyclin D1 Proteins in Premalignant Lesions and Carcinomas of the Colorectal Mucosa.
Sang Dae LEE ; Tae Jin LEE ; Eon Sub PARK
The Korean Journal of Gastroenterology 2008;52(6):359-367
BACKGROUND/AIMS: Nuclear factor-kappa B p65 (NF-kappa B p65), nuclear factor-kappa B1 p50 (NF-kappa B p50) have been shown to play a role in cell proliferation, apoptosis, cytokine production, and oncogenesis. Recently, p38 mitogen-activated protein kinase (MAPK)/ NF-kappa B/ cyclin D1 signaling pathway has been shown to play an important part in the pathogenesis of human cancers. This study was designed to investigate the expression of NF-kappa B p65, NF-kappa B p50, p38 MAPK alpha, and cyclin D1 proteins in premalignant lesions of colon and colorectal adenocarcinoma. METHODS: Paraffin sections of 20 normal mucosa, 20 low-grade tubular adenoma, 20 high-grade tubular adenoma and 64 adenocarcinoma tissues were analysed immunohistochemically for the expression of NF-kappa B p65, NF-kappa B p50, p38 MAPK alpha, and cyclin D1 proteins. RESULTS: The expression of NF-kappa B p65, NF-kappa B p50, and p38 MAPK alpha proteins were significantly higher in adenocarcinoma tissue in comparison with that in normal mucosa, low-grade tubular adenoma, and high-grade tubular adenoma tissues. Expression of NF-kappa B p50 was more frequent in poorly differentiated histologic grade, presence of nodal metastasis, and advanced stage. Expression of p38 MAPK alpha protein was higher in advanced tumor stage, presence of nodal metastasis and advanced stage. Synchronous expression of NF-kappa B p65, NF-kappa B p50, p38 MAPK alpha, and cyclin D1 proteins were significantly higher in adenocarcinoma tissue. CONCULSIONS: With the increased expression of NF-kappa B p65, NF-kappa B p50, and p38 MAPK alpha proteins, p38 MAPK/ NF-kappa B/ cyclin D1 signaling pathway may play a role in the pathogenesis of colorectal carcinoma.
Adenocarcinoma/enzymology/*metabolism/pathology
;
Colorectal Neoplasms/enzymology/*metabolism/pathology
;
Cyclin D1/immunology/*metabolism
;
Data Interpretation, Statistical
;
Female
;
Humans
;
Immunohistochemistry
;
Intestinal Mucosa/metabolism
;
Male
;
Middle Aged
;
NF-kappa B/immunology/*metabolism
;
NF-kappa B p50 Subunit/immunology/metabolism
;
Neoplasm Staging
;
Precancerous Conditions/enzymology/*metabolism
;
Transcription Factor RelA/immunology/metabolism
;
p38 Mitogen-Activated Protein Kinases/*metabolism